Genetic analysis of the cooperative tumorigenic effects of targeted deletions of tumor suppressors Rb1, Trp53, Men1, and Pten in neuroendocrine tumors in mice Journal Article


Authors: Xu, E. Y.; Vosburgh, E.; Wong, C.; Tang, L. H.; Notterman, D. A.
Article Title: Genetic analysis of the cooperative tumorigenic effects of targeted deletions of tumor suppressors Rb1, Trp53, Men1, and Pten in neuroendocrine tumors in mice
Abstract: Genetic alterations of tumor suppressor genes (TSGs) are frequently observed to have cumulative or cooperative tumorigenic effects. We examined whether the TSGs Rb1, Trp53, Pten and Men1 have cooperative effects in suppressing neuroendocrine tumors (NETs) in mice. We generated pairwise homozygous deletions of these four genes in insulin II gene expressing cells using the Cre-LoxP system. By monitoring growth and examining the histopathology of the pituitary (Pit) and pancreas (Pan) in these mice, we demonstrated that pRB had the strongest cooperative function with PTEN in suppressing PitNETs and had strong cooperative function with Menin and TRP53, respectively, in suppressing PitNETs and PanNETs. TRP53 had weak cooperative function with PTEN in suppressing pituitary lesions. We also found that deletion of Pten singly led to prolactinomas in female mice, and deletion of Rb1 alone led to islet hyperplasia in pancreas. Collectively, our data indicated that pRB and PTEN pathways play significant roles in suppressing PitNETs, while the Menin-mediated pathway plays a significant role in suppressing PanNETs. Understanding the molecular mechanisms of these genes and pathways on NETs will help us understand the molecular mechanisms of neuroendocrine tumorigenesis and develop effective preclinical murine models for NET therapeutics to improve clinical outcomes in humans. © Xu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Keywords: controlled study; survival rate; unclassified drug; gene deletion; histopathology; nonhuman; comparative study; genetic analysis; mouse; phenotype; animal tissue; gene expression; animal experiment; animal model; immunoreactivity; protein p53; enzyme linked immunosorbent assay; histology; growth hormone; carcinogenesis; neuroendocrine tumor; tumor suppressor gene; phosphatidylinositol 3,4,5 trisphosphate 3 phosphatase; glucose blood level; pten; trp53; pancreas islet cell hyperplasia; neuroendocrine tumors; synaptophysin; prolactin; clinical outcome; loxp site; rb1; prolactinoma; male; female; article; multiple endocrine neoplasia type 1; men1; rb transcriptional corepressor 1; antitumorigenic activity
Journal Title: Oncotarget
Volume: 11
Issue: 28
ISSN: 1949-2553
Publisher: Impact Journals  
Date Published: 2020-07-14
Start Page: 2718
End Page: 2739
Language: English
DOI: 10.18632/oncotarget.27660
PROVIDER: scopus
PMCID: PMC7367653
PUBMED: 32733644
DOI/URL:
Notes: Article -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Laura Hong Tang
    447 Tang